These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 2870541)

  • 1. [Almitrine bismesylate].
    Duroux P
    Rev Mal Respir; 1985; 2 Suppl 1():S1-2. PubMed ID: 2870541
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of chronic obstructive bronchitis with almitrine].
    Pilheu JA
    Medicina (B Aires); 1987; 47(4):442. PubMed ID: 2898724
    [No Abstract]   [Full Text] [Related]  

  • 3. [Almitrine dimesylate (vectarion)--the first representative of a new group of "synergetic" drugs--and its use in pulmonary pathology].
    Mihalţan F
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1987; 36(3):209-19. PubMed ID: 2894713
    [No Abstract]   [Full Text] [Related]  

  • 4. [Almitrine bismesylate. A peripheral chemoreceptor agonist].
    Nielsen SP
    Ugeskr Laeger; 1988 Nov; 150(46):2797-800. PubMed ID: 2905090
    [No Abstract]   [Full Text] [Related]  

  • 5. [Almitrine dimesylate: deductions and therapeutic prospects].
    Tellier P; Voisin C
    Presse Med; 1984 Oct; 13(34):2099-103. PubMed ID: 6149539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Microfluorimetric study of the effect of almitrine bismesylate (Vectarion) on intrapulmonary neuroepithelial bodies].
    Lauweryns JM; van Lommel A; van Meerbeek J
    Rev Mal Respir; 1985; 2 Suppl 1():S35-7. PubMed ID: 2870545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The effect of almitrine dimesylate on pulmonary hemodynamics in healthy subjects and in patients with chronic obstructive bronchitis].
    Ansquer JC
    Prax Klin Pneumol; 1988 Jun; 42 Suppl 1():409-10. PubMed ID: 2902612
    [No Abstract]   [Full Text] [Related]  

  • 8. [Originality of the mode of action of almitrine dimesylate].
    Tellier P
    Presse Med; 1984 Oct; 13(34):2083-9. PubMed ID: 6149536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacodynamic and pharmacokinetic interactions of almitrine bismesylate.
    Campbell DB; Gordon BH; Ings RM
    Rev Mal Respir; 1985; 2 Suppl 1():S39-44. PubMed ID: 2870546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Long-term (6 months) treatment of chronic bronchitis with respiratory insufficiency using almitrine dimesylate. Double-blind study versus placebo].
    Paramelle B; Joubert C; Dain MP
    Presse Med; 1984 Oct; 13(34):2094-8. PubMed ID: 6149538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drugs recently released in Belgium: misoprostol, almitrine bismesylate.
    Harvengt C
    Acta Clin Belg; 1986; 41(6):437-40. PubMed ID: 2883795
    [No Abstract]   [Full Text] [Related]  

  • 12. [Peripheral axonic neuropathy during treatment with almitrine bismesylate (Vectarion). Possible role of wasting].
    Gherardi R; Louarn F; Perrier M; Eizenbaum JF
    J Toxicol Clin Exp; 1985; 5(6):393-7. PubMed ID: 2878072
    [No Abstract]   [Full Text] [Related]  

  • 13. The assessment of almitrine bismesylate in the long-term treatment of chronic obstructive bronchitis.
    Marsac J
    Eur J Respir Dis Suppl; 1986; 146():685-93. PubMed ID: 3096766
    [No Abstract]   [Full Text] [Related]  

  • 14. [The almitrine dimesylate molecule. Various structure-activity relationship aspects].
    Labrid C; Regnier G
    Presse Med; 1984 Oct; 13(34):2059-62. PubMed ID: 6149532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long term almitrine bismesylate treatment in patients with chronic bronchitis and emphysema: a multicentre double-blind placebo controlled study.
    Arnaud F; Bertrand A; Charpin J; Chretien J; Decroix G; Guerrin F; Kalb JC; Lissac J; Michel FB; Morere P
    Eur J Respir Dis Suppl; 1983; 126():323-36. PubMed ID: 6373343
    [No Abstract]   [Full Text] [Related]  

  • 16. [Therapeutic importance and tolerance of coated 50 mg Vectarion tablets (almitrine bismesylate) at a dosage of 100 mg/day. Study of blood gas, clinical and biological results after a year of long-term treatment].
    Ansquer JC; Bertrand A; Blaive B; Charpin J; Chrétien J; Decroix G; Kalb JC; Lissac J; Michel FB; Morère P
    Rev Mal Respir; 1985; 2 Suppl 1():S61-7. PubMed ID: 2870549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Almitrine and peripheral nerve function.
    Lerebours G; Moore N; Senant J
    Lancet; 1988 Oct; 2(8614):799-800. PubMed ID: 2901646
    [No Abstract]   [Full Text] [Related]  

  • 18. The carotid bodies of spontaneously hypertensive rats (SHR) after long-term stimulation by almitrine bismesylate.
    Habeck JO; Huckstorf C; Mewes H
    Biomed Biochim Acta; 1988; 47(6):543-5. PubMed ID: 2907295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pulmonary hemodynamic effects of intravenous almitrine in patients with chronic bronchitis and respiratory insufficiency].
    Weitzenblum E; Ehrhart M; Schneider JC; Hirth C; Roegel E
    Bull Eur Physiopathol Respir; 1982; 18(5):765-73. PubMed ID: 6152773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Almitrine bismesylate.
    Tweney J; Howard P
    Z Erkr Atmungsorgane; 1987; 168(3):197-215. PubMed ID: 2890242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.